By Louise Rasmussen and Michael Erman COPENHAGEN (Reuters) -Novo Nordisk and Pfizer Inc separately released data on Monday showing that pills from the same class as Novo’s increasingly popular weight loss drugs such as Wegovy are about as effective as those injected medicines, giving shares of both companies a boost. Novo Nordisk said data from…
(Reuters) – Walmart Inc said on Monday it has signed a deal with pet telehealth provider Pawp to offer the retailer’s subscribed members access to veterinary professionals via video or text without an appointment. Walmart+ customers can use Pawp’s services for a year from Tuesday, the top U.S. retailer said, as it looks to tap growing…
By Raghav Mahobe (Reuters) -Ironwood Pharmaceuticals Inc said on Monday it would buy Switzerland-based drug developer VectivBio Holding AG for $1.15 billion, adding a promising treatment for digestive disorders to its portfolio. Ironwood has offered $17 per share for VectivBio, a premium of about 43% to the stock’s last close. VectivBio’s shares were at $16.21…
By Mike Scarcella (Reuters) – National retail pharmacy giant Walgreen Co has asked a U.S. judge to vacate an arbitrator’s award of more than $642 million to Humana Health Plan Inc in a drug-pricing dispute, calling the “staggering” sum the result of a “miscarriage of justice.” Lawyers for Walgreens made their legal challenge in a…
By Sybille de La Hamaide PARIS (Reuters) -Governments should consider vaccinating poultry against bird flu, which has killed hundreds of millions of birds and infected mammals worldwide, to prevent the virus from turning into a new pandemic, the head of the World Organisation for Animal Health (WOAH) said. The severity of the current outbreak of…
CAIRO/DUBAI (Reuters) -Sudan’s warring factions signed an agreement late on Saturday for a seven-day ceasefire as fighting that has plunged the country into chaos and displaced more than a million entered its sixth week. The ceasefire will take effect at 9:45 p.m. Khartoum time (1945 GMT) on Monday, the sponsors of the talks, the United…
By Djaffar Sabiti GOMA, Democratic Republic of Congo (Reuters) – Four men with machetes were hard on their heels as a group of women raced through the dense forest surrounding east Congo’s city of Goma, desperate to reach a displacement camp they had left to collect firewood. One tripped on a stone and fell. She…
By Leroy Leo and Sriparna Roy (Reuters) -A panel of advisers to the U.S. Food and Drug Administration, wary of the safety of Intercept Pharmaceuticals’ oral drug for a type of fatty liver disease, recommended on Friday holding off on an accelerated approval of the medicine. The panel of outside experts voted 15-to-1 against the…
By Mariam Sunny (Reuters) -The U.S. Food and Drug Administration has approved AbbVie Inc and Danish drugmaker Genmab’s blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said on Friday. The therapy, epcoritamab, which will be sold under the brand name Epkinly, treats a type of…
By Jennifer Rigby DUBLIN (Reuters) – Taking Novo Nordisk’s new obesity drug may help reduce the risk of heart disease as well as boosting weight loss, according to new research from the United States. After a year of taking semaglutide, marketed as Wegovy, patients’ risk of suffering from conditions like a heart attack or a…
